|
1
|
Das S and Das DK: Resveratrol: a
therapeutic promise for cardiovascular diseases. Recent Patents
Cardiovasc Drug Discov. 2:133–138. 2007. View Article : Google Scholar
|
|
2
|
Chen H, Tuck T, Ji X, Zhou X, Kelly G,
Cuerrier A and Zhang J: Quality assessment of Japanese knotweed
(Fallopia japonica) grown on Prince Edward Island as a source of
resveratrol. J Agric Food Chem. 61:6383–6392. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Du QH, Peng C and Zhang H: Polydatin: a
review of pharmacology and pharmacokinetics. Pharm Biol.
51:1347–1354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen L, Lan Z, Lin Q, Mi X, He Y, Wei L,
Lin Y, Zhang Y and Deng X: Polydatin ameliorates renal injury by
attenuating oxidative stress-related inflammatory responses in
fructose-induced urate nephropathic mice. Food Chem Toxicol.
52:28–35. 2013. View Article : Google Scholar
|
|
5
|
Wen H, Gao X and Qin J: Probing the
anti-aging role of polydatin in Caenorhabditis elegans on a chip.
Integr Biol (Camb). 6:35–43. 2014. View Article : Google Scholar
|
|
6
|
Blanc A, Pandey NR and Srivastava AK:
Synchronous activation of ERK 1/2, p38mapk and PKB/Akt signaling by
H2O2 vascular smooth muscle cells: potential
involvement in vascular 2 2 in disease (Review). Int J Mol Med.
11:229–234. 2003.PubMed/NCBI
|
|
7
|
Jiang D, Li D and Wu W: Inhibitory effects
and mechanisms of luteolin on proliferation and migration of
vascular smooth muscle cells. Nutrients. 5:1648–1659. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lan TH, Huang XQ and Tan HM: Vascular
fibrosis in atherosclerosis. Cardiovasc Pathol. 22:401–407. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang X, Liu W, Deng J, Lan L, Xue X,
Zhang C, Cai G, Luo X and Liu J: Polydatin protects cardiac
function against burn injury by inhibiting sarcoplasmic reticulum
Ca2+ leak by reducing oxidative modification of
ryanodine receptors. Free Radic Biol Med. 60:292–299. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao KS, Jin C, Huang X, Liu J, Yan WS,
Huang Q and Kan W: The mechanism of polydatin in shock treatment.
Clin Hemorheol Microcirc. 29:211–217. 2003.
|
|
11
|
Salminen A, Kaarniranta K and Kauppinen A:
Crosstalk between oxidative stress and SIRT1: Impact on the aging
process. Int J Mol Sci. 14:3834–3859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H, Zhai Z, Wang Y, Zhang J, Wu H,
Wang Y, Li C, Li D, Lu L, Wang X, et al: Resveratrol ameliorates
ionizing irradiation-induced long-term hematopoietic stem cell
injury in mice. Free Radic Biol Med. 54:40–50. 2013. View Article : Google Scholar
|
|
13
|
Zarzuelo MJ, López-Sepúlveda R, Sánchez M,
Romero M, Gómez-Guzmán M, Ungvary Z, Pérez-Vizcaíno F, Jiménez R
and Duarte J: SIRT1 inhibits NADPH oxidase activation and protects
endothelial function in the rat aorta: implications for vascular
aging. Biochem Pharmacol. 85:1288–1296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kao CL, Chen LK, Chang YL, Yung MC, Hsu
CC, Chen YC, Lo WL, Chen SJ, Ku HH and Hwang SJ: Resveratrol
protects human endothelium from H2O2-induced
oxidative stress and senescence via SirT1 activation. J Atheroscler
Thromb. 17:970–979. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gong X, Ma Y, Ruan Y, Fu G and Wu S:
Long-term atorvastatin improves age-related endothelial dysfunction
by ameliorating oxidative stress and normalizing eNOS/iNOS
imbalance in rat aorta. Exp Gerontol. 52:9–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Salabei JK, Cummins TD, Singh M, Jones SP,
Bhatnagar A and Hill BG: PDGF-mediated autophagy regulates vascular
smooth muscle cell phenotype and resistance to oxidative stress.
Biochem J. 451:375–388. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ni L, Li T, Liu B, Song X, Yang G, Wang L,
Miao S and Liu C: The protective effect of Bcl-xl overexpression
against oxidative stress-induced vascular endothelial cell injury
and the role of the Akt/eNOS pathway. Int J Mol Sci.
14:22149–22162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
San Martin A, Foncea R, Laurindo FR,
Ebensperger R, Griendling KK and Leighton F: Nox1-based NADPH
oxidase- derived superoxide is required for VSMC activation by
advanced glycation end-products. Free Radic Biol Med. 42:1671–1679.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Botden IP, Oeseburg H, Durik M, Leijten
FP, Van Vark-Van Der, Zee LC, Musterd-Bhaggoe UM, Garrelds IM,
Seynhaeve AL, Langendonk JG, Sijbrands EJ, et al: Red wine extract
protects against oxidative-stress-induced endothelial senescence.
Clin Sci (Lond). 123:499–507. 2012. View Article : Google Scholar
|
|
20
|
Wang Q, Zhou H, Gao H, Chen SH, Chu CH,
Wilson B and Hong JS: Naloxone inhibits immune cell function by
suppressing superoxide production through a direct interaction with
gp91phox subunit of NADPH oxidase. J Neuroinflammation.
9:322012. View Article : Google Scholar
|
|
21
|
Miranda KM, Espey MG and Wink DA: A rapid,
simple spectrophotometric method for simultaneous detection of
nitrate and nitrite. Nitric Oxide. 5:62–71. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi Y, Hou X, Zhang X, Wang Y, Chen Y and
Zou J: Inhibition of oxidized-phospholipid-induced vascular smooth
muscle cell proliferation by resveratrol is associated with
reducing Cx43 phosphorylation. J Agric Food Chem. 61:10534–10541.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prasad K: Resveratrol, wine, and
atherosclerosis. Int J Angiol. 21:7–18. 2012. View Article : Google Scholar :
|
|
24
|
Gutiérrez-Pérez A, Cortés-Rojo C,
Noriega-Cisneros R, Calderón-Cortés E, Manzo-Avalos S,
Clemente-Guerrero M, Godínez-Hernández D, Boldogh I and
Saavedra-Molina A: Protective effects of resveratrol on
calcium-induced oxidative stress in rat heart mitochondria. J
Bioenerg Biomembr. 43:101–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han X, Ling S, Gan W, Sun L, Duan J and Xu
JW: 2,3,5,4′-tetra-hydroxystilbene-2-O-β-d-glucoside ameliorates
vascular senescence and improves blood flow involving a mechanism
of p53 deacetylation. Atherosclerosis. 225:76–82. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park SJ, Ahmad F, Philp A, Baar K,
Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, et al:
Resveratrol ameliorates aging-related metabolic phenotypes by
inhibiting cAMP phosphodiesterases. Cell. 148:421–433. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Robb EL and Stuart JA: The stilbenes
resveratrol, pterostilbene and piceid affect growth and stress
resistance in mammalian cells via a mechanism requiring estrogen
receptor beta and the induction of Mn-superoxide dismutase.
Phytochemistry. 98:164–173. 2014. View Article : Google Scholar
|
|
28
|
Yang H, Baur JA, Chen A, Miller C, Adams
JK, Kisielewski A, Howitz KT, Zipkin RE and Sinclair DA: Design and
synthesis of compounds that extend yeast replicative lifespan.
Aging Cell. 6:35–43. 2007. View Article : Google Scholar
|
|
29
|
Szekeres T, Fritzer-Szekeres M, Saiko P
and Jäger W: Resveratrol and resveratrol analogues -
structure-activity relationship. Pharm Res. 27:1042–1048. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Storniolo CE, Quifer-Rada P,
Lamuela-Raventos RM and Moreno JJ: Piceid presents
antiproliferative effects in intestinal epithelial Caco-2 cells,
effects unrelated to resveratrol release. Food Funct. 5:2137–2144.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bicknell KA, Surry EL and Brooks G:
Targeting the cell cycle machinery for the treatment of
cardiovascular disease. J Pharm Pharmacol. 55:571–591. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bonelli P, Tuccillo FM, Borrelli A,
Schiattarella A and Buonaguro FM: CDK/CCN and CDKI alterations for
cancer pro gnosis and therapeutic predictivity. Biomed Res Int.
2014:3610202014. View Article : Google Scholar
|
|
33
|
Wang Z, Fan M, Candas D, Zhang TQ, Qin L,
Eldridge A, Wachsmann-Hogiu S, Ahmed KM, Chromy BA, Nantajit D, et
al: Cyclin B1/Cdk1 coordinates mitochondrial respiration for
cell-cycle G2/M progression. Dev Cell. 29:217–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Payne SR, Zhang S, Tsuchiya K, Moser R,
Gurley KE, Longton G, deBoer J and Kemp CJ: p27kip1
deficiency impairs G2/M arrest in response to DNA damage, leading
to an increase in genetic instability. Mol Cell Biol. 28:258–268.
2008. View Article : Google Scholar :
|
|
35
|
Wang J, Liu K, Shen L, Wu H and Jing H:
Small interfering RNA to c-myc inhibits vein graft restenosis in a
rat vein graft model. J Surg Res. 169:e85–e91. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Su D, Cheng Y, Liu M, Liu D, Cui H, Zhang
B, Zhou S, Yang T and Mei Q: Comparision of piceid and resveratrol
in anti-oxidation and antiproliferation activities in vitro. PLoS
One. 8:e545052013. View Article : Google Scholar
|
|
37
|
Huang J, Li LS, Yang DL, Gong QH, Deng J
and Huang XN: Inhibitory effect of ginsenoside Rg1 on vascular
smooth muscle cell proliferation induced by PDGF-BB is involved in
nitric oxide formation. Evid Based Complement Alternat Med.
2012:3143952012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gonon AT, Widegren U, Bulhak A, Salehzadeh
F, Persson J, Sjöquist PO and Pernow J: Adiponectin protects
against myocardial ischaemia-reperfusion injury via AMP-activated
protein kinase, Akt, and nitric oxide. Cardiovasc Res. 78:116–122.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Trott DW, Luttrell MJ, Seawright JW and
Woodman CR: Aging impairs PI3K/Akt signaling and NO-mediated
dilation in soleus muscle feed arteries. Eur J Appl Physiol.
113:2039–2046. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Takahashi S and Nakashima Y: Repeated and
long-term treatment with physiological concentrations of
resveratrol promotes NO production in vascular endothelial cells.
Br J Nutr. 107:774–780. 2012. View Article : Google Scholar
|
|
41
|
Ekshyyan VP, Hebert VY, Khandelwal A and
Dugas TR: Resveratrol inhibits rat aortic vascular smooth muscle
cell proliferation via estrogen receptor dependent nitric oxide
production. J Cardiovasc Pharmacol. 50:83–93. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hori YS, Kuno A, Hosoda R and Horio Y:
Regulation of FOXOs and p53 by SIRT1 modulators under oxidative
stress. PLoS One. 8:e738752013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Potente M and Dimmeler S: NO targets
SIRT1: A novel signaling network in endothelial senescence.
Arterioscler Thromb Vasc Biol. 28:1577–1579. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Thompson AM, Martin KA and Rzucidlo EM:
Resveratrol induces vascular smooth muscle cell differentiation
through stimulation of SirT1 and AMPK. PLoS One. 9:e854952014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tanno M, Kuno A, Horio Y and Miura T:
Emerging beneficial roles of sirtuins in heart failure. Basic Res
Cardiol. 107:2732012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xia N, Strand S, Schlufter F, Siuda D,
Reifenberg G, Kleinert H, Förstermann U and Li H: Role of SIRT1 and
FOXO factors in eNOS transcriptional activation by resveratrol.
Nitric Oxide. 32:29–35. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Takizawa Y, Kosuge Y, Awaji H, Tamura E,
Takai A, Yanai T, Yamamoto R, Kokame K, Miyata T, Nakata R and
Inoue H: Up-regulation of endothelial nitric oxide synthase (eNOS),
silent mating type information regulation 2 homologue 1 (SIRT1) and
autophagy-related genes by repeated treatments with resveratrol in
human umbilical vein endothelial cells. Br J Nutr. 110:2150–2155.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ota H, Eto M, Ogawa S, Iijima K, Akishita
M and Ouchi Y: SIRT1/eNOS axis as a potential target against
vascular senescence, dysfunction and atherosclerosis. J Atheroscler
Thromb. 17:431–435. 2010. View Article : Google Scholar : PubMed/NCBI
|
